Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Daisy
Daisy Carbajal Quintana, Habana CU
| Patent application number | Description | Published |
|---|---|---|
| 20100021574 | Pharmaceutical Composition and Procedure to Treat and Prevent Prostatic Hyperplasia and Prostatitis from the Royal Palm (Roystonea regia) Fruits - A method for obtaining a pharmaceutical composition from | 01-28-2010 |
| 20100022649 | Pharmaceutical Composition and Procedure to Treat and Prevent Prostatic Hyperplasia and Prostatitis From the Royal Palm (Roystonea regia) Fruits - A method for treating and/or preventing BPH prostatitis, alopecia and hirsutism including administering a medication of the pharmaceutical composition obtained from the green or mature fruits of | 01-28-2010 |
Daisy Flamez, Lennik BE
| Patent application number | Description | Published |
|---|---|---|
| 20100322850 | NEW PLASMA MEMBRANE BIOMARKERS PREFERENTIALLY EXPRESSED IN PANCREATIC BETA CELLS USEFUL IN IMAGING OR TARGETING BETA CELLS - The present invention is directed to the identification of a biomarker specifically located in the plasma membrane of pancreatic beta cells. It was selected by a Systems Biology approach on Massively Parallel Signal Sequencing datasets obtained in human islets and Affymetrix microarray datasets on human islets, purified rat primary beta and non beta cells and insulinoma cells. Based on a set of specific features the biomarker is a unique candidate for imaging and targeting strategies to study the pancreatic beta cell mass in health and disease (T1 D, T2D, pancreatic cancers, obesity, islet transplantation, beta cell regeneration). The five specific features of the selected biomarkers are: 1) Preferentially expressed in pancreatic islets as compared to surrounding tissues; 2) Higher expression in pancreatic beta cells than in pancreatic alpha cells or than in other islet non-beta cells; 3) Expression levels in pancreatic beta cells are higher or comparable to glucokinase which is an enzyme specifically expressed in the pancreatic beta cell; 4) Located in the membrane and as such targetable with antibodies, peptides or small molecules which allows imaging, targeting and immunohistochemistry; and 5) Expression is not induced during the process of inflammation of the beta cell mass and the protein is not enriched in T-cells and dendritic cells or in other cells participating in the inflammation process. | 12-23-2010 |
Daisy Pireh, Lake Forest, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20100190822 | Pharmaceutical Compositions As Inhibitors of Dipeptidyl Peptidase-IV (DPP-IV) - The present invention relates to compounds which inhibit dipeptidyl peptidase IV (DPP-IV) and are useful for the prevention or treatment of diabetes, especially type II diabetes, as well as hyperglycemia, Syndrome X, hyperinsulinemia, obesity, atherosclerosis, and various immunomodulatory diseases. | 07-29-2010 |
Daisy Red, Royal Oak, MI US
| Patent application number | Description | Published |
|---|---|---|
| 20110137432 | AUTOMATION MANAGEMENT SYSTEM AND METHOD - A method for monitoring performance of at least one task in controlled equipment is disclosed herein. The method includes collecting a series of signals associated with the at least one task, at least some of the signals in the series define timing values for the at least one task. comparing each of at least some of the timing values to a reference value, generating an accumulated variance value based on the comparisons and selectively generating a predictive failure indication based on the generated accumulated variance value. | 06-09-2011 |
Daisy Red, Southfield, MI US
| Patent application number | Description | Published |
|---|---|---|
| 20110209321 | MODULAR MANUFACTURING FACILITY AND METHOD - A modular manufacturing facility and method of construction includes a plurality of service and equipment modules which are readily sized and oriented to be packaged, shipped to a desired location, assembled and connected to local resources to form a fully operational assembly or build facility substantially or wholly independent of any resident building structure at the selected site. | 09-01-2011 |
Daisy Tan, Toronto CA
| Patent application number | Description | Published |
|---|---|---|
| 20090070189 | BUSINESS DOMAIN LEVEL SPECIFICATION OF A MARKETING CAMPAIGN - Embodiments of the present invention address deficiencies of the art in respect to the customer experience marketing component of an e-commerce system and provide a novel and non-obvious method, system and computer program product for specifying marketing campaigns in an e-commerce system at a business domain level. In one embodiment of the invention, a method for specifying marketing campaigns in an e-commerce system at a business domain level can include specifying criteria for triggering a marketing campaign for a specific customer through a form based user interface, generating monitoring criteria for monitoring customer behavior for the specific customer from the specified criteria, monitoring customer behavior according to the monitoring criteria, and triggering a marketing campaign for the specific customer only when observing customer behavior consistent with the monitoring criteria when monitoring the customer behavior. | 03-12-2009 |